PI
PHOTRONICS INC (PLAB)·Q4 2024 Earnings Summary
Executive Summary
- Q4 revenue of $222.6M rose 6% q/q and came in above the high end of prior guidance ($213–$221M); non-GAAP EPS of $0.59 also exceeded the guided range ($0.48–$0.54) as high-end IC and G10.5+ FPD drove mix, while GAAP EPS was $0.54 .
- Operating margin was 25.1% in Q4 (flat-to-up q/q), with gross margin ~37%; opex elevated on R&D qualification activity and outside services, though management targets opex returning to ~10% of revenue going forward .
- Q1 FY25 guidance embeds typical seasonality and Lunar New Year: revenue $208–$216M, operating margin 23–25%, non-GAAP EPS $0.43–$0.49, taxes $17–$19M; full-year FY25 capex planned at ~$200M, focused on expanding U.S. IC capacity to capture regionalization-driven demand .
- Balance sheet remains a strength: cash and ST investments $640.7M vs. $606.4M in Q3; debt down to $18.0M. $100M repurchase authorization in place supports capital return optionality alongside growth investments .
What Went Well and What Went Wrong
-
What Went Well
- High-end IC strength: +21% q/q high-end IC sales on stronger logic foundry demand in the U.S. and Asia; overall IC revenue +5% q/q to $163.7M .
- Execution vs guidance: Q4 revenue ($222.6M) and non-GAAP EPS ($0.59) both exceeded guided ranges; management cited favorable photomask demand into year-end .
- Cash generation and liquidity: Q4 OCF $68.4M; cash & ST investments $640.7M; debt reduced to $18.0M, providing flexibility for U.S. capacity expansion and buybacks .
-
What Went Wrong
- Year-over-year declines: Revenue -2% y/y; GAAP EPS fell to $0.54 from $0.72; FPD revenue -7% y/y on softer premium smartphone demand .
- Opex uptick: SG&A and R&D rose due to qualification activity and outside services; management expects normalization to ~10% of revenue, but near-term headwind persisted in Q4 .
- Limited visibility and uneven demand: Management emphasized 1–3 week backlog and high ASP sensitivity to a small number of high-end orders; mainstream IC mid-quarter softness, though stabilized late in quarter .
Financial Results
Notes:
- Q4 results vs estimates: Wall Street consensus from S&P Global was unavailable at time of analysis due to data access limits; comparisons to consensus are therefore not shown (see “Estimates Context”) [GetEstimates error].
Segment revenue (Q4 2024):
- IC: $163.7M (-1% y/y, +5% q/q); High-end $60.1M (+4% y/y, +21% q/q), Mainstream $103.7M (-3% y/y, -3% q/q) .
- FPD: $58.9M (-7% y/y, +7% q/q); High-end $48.4M (-9% y/y, flat q/q), Mainstream $10.5M (+8% y/y, +57% q/q) .
KPIs and balance sheet (quarter-end):
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We delivered a strong fourth quarter with sales above the high end of guidance... demand turned positively this quarter, primarily for high-end designs in Asia and the U.S.” – Frank (KangJyh) Lee, CEO .
- “Gross margin of 37% in Q4 was flat year-over-year... We anticipate operating expenses returning to our target of 10% of revenue.” – Eric Rivera, CFO .
- “In 2025, we anticipate CapEx will grow to $200 million with most of the increase earmarked to expand our IC investment in the U.S.” – Eric Rivera .
- “AI ecosystem... peripheral circuitry around the GPU... edge network chips... memory in data centers... ASICs for inference.” – Christopher Progler, executive .
Q&A Highlights
- OpEx normalization: Elevated SG&A and R&D in Q4 (some nonrecurring labor/benefits and outside services). Management expects OpEx to revert to ~10% of revenue .
- FY25 capex ($200M): Majority for new capacity (not greenfield) primarily in the U.S.; some tool replacements; supports both current and new fabs over next ~3 years .
- Mainstream IC health: Supply-demand imbalances have rationalized; mainstream remains healthy, with stable to growing demand in U.S./Europe/Taiwan; some competitive pressure in China .
- Industry growth: Photomask demand seen growing over next three years, with AI and regionalization as drivers; focus on raising mix in China, and U.S. capacity/capability expansion .
- AI exposure: Commercial opportunities in edge/network chips, AI-tuned memory, and ASICs for inference, even as leading-edge GPU masks remain largely captive .
Estimates Context
- S&P Global consensus for Q4 FY2024 (revenue and EPS) was not available at time of analysis due to data access limits; as a result, explicit comparisons to Wall Street consensus are not shown. We anchored evaluation to company guidance and actuals (beats vs prior guidance) and will update estimates context upon access restoration [GetEstimates error].
Key Takeaways for Investors
- Mix recovery and execution: Sequential rebound led by high-end IC (+21% q/q) and mainstream FPD; both revenue and non-GAAP EPS beat the high end of guidance, underscoring execution in an uneven demand environment .
- Margin resilience: Operating margin held 25.1% despite higher opex from qualification activity; management targets OpEx normalization to ~10% of revenue, a potential EPS tailwind as volumes grow .
- Capacity-led growth strategy: FY25 capex of ~$200M focused on U.S. multi-site IC capacity/capability is a key medium-term growth lever tied to regionalization and customer commitments; expect returns as new projects ramp through mid-2026 .
- Liquidity strength: $640.7M cash & ST investments with only $18.0M debt provides ample flexibility for capex, M&A, and up to $100M buybacks; balance sheet de-risks execution .
- Near-term seasonality: Q1 FY25 guide reflects Lunar New Year and typical seasonality; investors should expect a softer first quarter before potential reacceleration with AI/ASIC projects and U.S. capacity adds .
- Demand drivers broadening: AI-related edge/network chips, data center memory, and inference ASICs offer accessible growth vectors for merchant photomasks beyond captive GPU masks .
- Watch items: Visibility remains limited (1–3 week backlog) and premium smartphone demand softness can weigh on high-end FPD; competitive dynamics in China mainstream warrant mix discipline .
Other relevant Q4 period press releases:
- Participation in 13th Annual NYC Summit (Dec 12, 2024) .
- Board member appointment (Dec 18, 2024) .
- Hiring of VP & General Counsel (Nov 21, 2024) .
Citations:
- Q4 FY24 8-K press release, financials, and slides .
- Q4 FY24 standalone press release mirror .
- Q4 FY24 earnings call transcript .
- Q3 FY24 8-K, financials, and slides for prior-quarter comparisons and guidance .
- Q2 FY24 8-K and slides for trend analysis .